Detecting and Controlling Arrytmia by self monitoring of ECG at Home

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23408

Enrollment

Registered

2015-08-07

Start date

2015-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

history referring to a possible arrhythmia patients using a potent arrhythmogenic drug. Keywords: smartphone

Interventions

selfmonitoring of ecg at home usingd the AliveCor Heart Monitor, a new technology in which a ECG computer chip and sensors are integrated in the case of an iPhone.

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a history referring to a possible arrhythmia, not or incompletely recorded in prior examinations and patients using a potent arrhythmogenic drug.

Exclusion criteria

Exclusion criteria: patients not able to work with a smartphone, even after ample instruction.

Design outcomes

Primary

Measure	Time frame
Does self monitoring of the ECG by the patient contribute to the correct diagnosis, reduce the frequency of cardiology consultations and lead to less side effects and lower dosage of medication, such as beta blockers and Class 3 arithmetic’s? •Do patients become more confident and gain more insight into their own performance? •Have patients easily mastered the technique?	—

Contacts

Public ContactP.F.H.M Höppener

Zuyderland MC Heerlen

paulhop37@hotmail.nltel: 045 5710420

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)